We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
676
Kimberly-Clark
KMB
$36.4B
$10.3M 0.02%
106,600
-283,033
-73% -$29M
IMVT icon
677
Immunovant
IMVT
$8.09B
$10.3M 0.02%
413,000
-450,000
-52% -$11.7M
ACI icon
678
Albertsons Companies
ACI
$5.4B
$10.3M 0.02%
601,637
+100,000
+20% +$1.74M
GNRC icon
679
Generac Holdings
GNRC
$11.9B
$10.2M 0.02%
52,358
-600
-1% -$115K
B
680
Barrick Mining
B
$62.2B
$10.2M 0.02%
250,000
-430,000
-63% -$19.9M
DOC icon
681
Healthpeak Properties
DOC
$15.4B
$10.2M 0.02%
620,143
+52,700
+9% +$903K
PRQR icon
682
ProQR Therapeutics
PRQR
$243M
$10.1M 0.02%
6,253,467
XHR
683
Xenia Hotels & Resorts
XHR
$1.98B
$10.1M 0.02%
681,781
+131,781
+24% +$1.99M
WLIIU
684
Willow Lane Acquisition Corp II Unit
WLIIU
$10.1M 0.02%
+1,000,000
New +$10.1M
KPTI icon
685
Karyopharm Therapeutics
KPTI
$168M
$10.1M 0.02%
1,806,322
+1,385,000
+329% +$10.6M
RARE icon
686
Ultragenyx Pharmaceutical
RARE
$2.65B
$10.1M 0.02%
480,000
+200,000
+71% +$4.5M
MBVI
687
M3-Brigade Acquisition VI Corp
MBVI
$439M
$10.1M 0.02%
1,000,000
BDCI
688
BTC Development Corp
BDCI
$9.99M 0.02%
1,000,000
GDDY icon
689
GoDaddy
GDDY
$12.3B
$9.97M 0.02%
120,600
+38,600
+47% +$3.66M
POOL icon
690
Pool Corp
POOL
$6.7B
$9.95M 0.02%
49,200
-290,516
-86% -$68.5M
DPZ icon
691
Domino's
DPZ
$11B
$9.95M 0.02%
27,739
-300
-1% -$118K
INDB icon
692
Independent Bank
INDB
$4.05B
$9.91M 0.02%
131,818
+102,839
+355% +$8.06M
GL icon
693
Globe Life
GL
$13.5B
$9.88M 0.02%
71,000
-900
-1% -$127K
IQV icon
694
IQVIA
IQV
$34.7B
$9.87M 0.02%
57,852
-30,608
-35% -$5.97M
BKD icon
695
Brookdale Senior Living
BKD
$3.62B
$9.71M 0.02%
+710,000
New +$9.95M
SPOT icon
696
Spotify
SPOT
$99.2B
$9.7M 0.02%
+20,000
New +$10M
WWD icon
697
Woodward
WWD
$25B
$9.66M 0.01%
+26,988
New +$9.72M
MMSI icon
698
Merit Medical Systems
MMSI
$4.43B
$9.65M 0.01%
140,000
-25,000
-15% -$1.95M
TGT icon
699
Target
TGT
$62.1B
$9.41M 0.01%
77,679
-220,100
-74% -$24.8M
ALSN icon
700
Allison Transmission
ALSN
$10.1B
$9.36M 0.01%
+80,000
New +$9.09M

Similar funds

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.